Park Medi World Limited Acquires Febris Multi-speciality Hospital for ₹50.68 Crores
Park Medi World Limited's subsidiary, Blue Heavens Healthcare Private Limited, has acquired Febris Multi-speciality Hospital in Narela, New Delhi, for ₹50.68 crores. The acquisition involves 100% shareholding in Durha Vitrak Private Limited, which owns the 200-bed hospital. This strategic move aligns with Park Group's expansion plans, aiming to increase their hospital count from 14 to 20 and bed capacity from 3,250 to 5,260 by March 2028. The acquisition is expected to provide affordable healthcare services in the densely populated Narela area.

*this image is generated using AI for illustrative purposes only.
Park Medi World Limited has successfully acquired Febris Multi-speciality Hospital in Narela, New Delhi, through its wholly-owned subsidiary Blue Heavens Healthcare Private Limited. The acquisition, valued at ₹50.68 crores, was completed through the corporate insolvency resolution process.
Acquisition Details
The transaction involved acquiring 100% shareholding in Durha Vitrak Private Limited, which owns and operates Febris Multi-speciality Hospital. The acquisition was structured as a cash transaction through the corporate insolvency resolution process under the Insolvency and Bankruptcy Code, 2016.
| Parameter | Details |
|---|---|
| Acquisition Cost | ₹50.68 crores |
| Shareholding Acquired | 100% |
| Transaction Type | Cash consideration |
| Acquiring Entity | Blue Heavens Healthcare Private Limited |
Hospital Infrastructure and Capacity
Febris Multi-speciality Hospital is designed as a 200-bed multi-speciality healthcare facility constructed over 1,10,000 square feet of covered area. The hospital is strategically located in Narela, New Delhi, providing easy accessibility from districts in Haryana and Uttar Pradesh, particularly rural areas.
The target entity, Durha Vitrak Private Limited, was incorporated on August 1, 1986, with its registered office at Plot No. 20, Sector A-7 Narela, Delhi. The company has an authorized capital of ₹10 crores and paid-up capital of ₹10 lakhs. However, the entity was under corporate insolvency resolution process and remained non-operational since 2019, resulting in no revenue generation in the last three years.
Strategic Impact and Objectives
The acquisition aligns with Park Group's cluster-based growth model and expansion strategy. Located in the densely populated area of Narela, the facility is positioned to bridge the healthcare gap for low-income families by providing dependable, high-quality medical services at affordable rates.
| Growth Metrics | Current Status | Target (March 2028) |
|---|---|---|
| Number of Hospitals | 14 operational | Additional 6 under integration |
| Current Bed Capacity | 3,250 beds | 5,260 beds |
| Additional Beds from Expansion | - | 1,810 beds |
Dr. Ankit Gupta, Managing Director of Park Medi World Limited, stated that the acquisition reinforces the company's commitment to making affordable, world-class healthcare accessible across the Northern Region. The hospital will strengthen the regional network while upholding the group's mission of wellness for all.
Company Background
Park Group operates as North India's second-largest hospital chain, currently managing 14 hospitals with a combined capacity of 3,250 beds. The group has established presence across key cities including Delhi, Gurgaon, Faridabad, Panipat, Karnal, Sonipat, Ambala, Mohali, Patiala, Bathinda, Behror, and Jaipur.
The healthcare services span multiple super-specialities including cardiology, neurology, oncology, orthopaedics, gastroenterology, critical care, nephrology, and women and child health. Each facility is equipped with modern medical infrastructure, advanced diagnostics, 24x7 emergency support, and multi-disciplinary teams delivering evidence-based care.
Regulatory Compliance
The acquisition disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The transaction does not fall within related party transactions, and promoter/promoter group/group companies have no interest in the entity being acquired.





























